Expanding Diabetes Business Supports ABT Stock, FX Issues Stay
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...
Guidelines needed for interpreting continuous glucose monitoring reports in those without diabetes, say researchers
With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...
drugdeliverybusiness2d
Medtronic seeks to expand MiniMed 780G label to type 2 diabetes, submits new CGM to FDA
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Scientists Identify Cellular “Switch” That May Reverse Diabetes
Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.
The Lancet3d
Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies
Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...
denver73d
Company working to improve A1C readings for Black people facing diabetes
The team at Orange BIOMED is working on a device that will allow people of color to get more accurate A1C readings, which is a blood test that measures blood sugar to diagnose and monitor diabetes.